Logo image of ZONE

CLEANCORE SOLUTIONS INC-CL B (ZONE) Stock Fundamental Analysis

USA - NYSEARCA:ZONE - US1844921064 - Common Stock

3.8 USD
-0.18 (-4.52%)
Last: 9/12/2025, 8:27:10 PM
3.88 USD
+0.08 (+2.11%)
Pre-Market: 9/15/2025, 5:30:14 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ZONE. ZONE was compared to 128 industry peers in the Machinery industry. ZONE has a bad profitability rating. Also its financial health evaluation is rather negative. ZONE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ZONE had negative earnings in the past year.
In the past year ZONE has reported a negative cash flow from operations.
ZONE Yearly Net Income VS EBIT VS OCF VS FCFZONE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -54.85%, ZONE is doing worse than 89.84% of the companies in the same industry.
ZONE's Return On Equity of -152.27% is on the low side compared to the rest of the industry. ZONE is outperformed by 88.28% of its industry peers.
Industry RankSector Rank
ROA -54.85%
ROE -152.27%
ROIC N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZONE Yearly ROA, ROE, ROICZONE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

ZONE has a Gross Margin of 45.25%. This is amongst the best in the industry. ZONE outperforms 86.72% of its industry peers.
In the last couple of years the Gross Margin of ZONE has grown nicely.
The Profit Margin and Operating Margin are not available for ZONE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
ZONE Yearly Profit, Operating, Gross MarginsZONE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

2

2. Health

2.1 Basic Checks

ZONE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZONE has more shares outstanding
Compared to 1 year ago, ZONE has an improved debt to assets ratio.
ZONE Yearly Shares OutstandingZONE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
ZONE Yearly Total Debt VS Total AssetsZONE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

ZONE has an Altman-Z score of 4.54. This indicates that ZONE is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.54, ZONE is doing good in the industry, outperforming 75.78% of the companies in the same industry.
ZONE has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
ZONE has a worse Debt to Equity ratio (1.15) than 79.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Altman-Z 4.54
ROIC/WACCN/A
WACC10.24%
ZONE Yearly LT Debt VS Equity VS FCFZONE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 1.06 indicates that ZONE should not have too much problems paying its short term obligations.
ZONE has a worse Current ratio (1.06) than 85.94% of its industry peers.
A Quick Ratio of 0.68 indicates that ZONE may have some problems paying its short term obligations.
ZONE's Quick ratio of 0.68 is on the low side compared to the rest of the industry. ZONE is outperformed by 85.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.68
ZONE Yearly Current Assets VS Current LiabilitesZONE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

ZONE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.11%, which is quite impressive.
Looking at the last year, ZONE shows a very negative growth in Revenue. The Revenue has decreased by -34.26% in the last year.
ZONE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.36% yearly.
EPS 1Y (TTM)27.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-184.3%
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%-0.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZONE Yearly Revenue VS EstimatesZONE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZONE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZONE Price Earnings VS Forward Price EarningsZONE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZONE Per share dataZONE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZONE!.
Industry RankSector Rank
Dividend Yield N/A

CLEANCORE SOLUTIONS INC-CL B

NYSEARCA:ZONE (9/12/2025, 8:27:10 PM)

Premarket: 3.88 +0.08 (+2.11%)

3.8

-0.18 (-4.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.45%
Inst Owner Change9.62%
Ins Owners63.14%
Ins Owner Change46.8%
Market Cap52.33M
AnalystsN/A
Price TargetN/A
Short Float %1.18%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 31.85
P/FCF N/A
P/OCF N/A
P/B 23.71
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.12
BVpS0.16
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.85%
ROE -152.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.25%
FCFM N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.73%
Cap/Sales 1.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.68
Altman-Z 4.54
F-Score4
WACC10.24%
ROIC/WACCN/A
Cap/Depr(3y)62.75%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-184.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%-0.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-338.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-337.14%
OCF growth 3YN/A
OCF growth 5YN/A